Future Medicine

Epsiode 38: Out of the Lab, Into the Code: An Age of AI Scientists?

Epsiode 38: Out of the Lab, Into the Code: An Age of AI Scientists?

For Episode 38 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow discuss the benefits and challenges of AI co-scientists, which can condense the work of weeks, months, or even years of reading, debate, and hour-long lab meetings into minutes.

Researchers at Stanford University and Google DeepMind have released multi-agent AI “scientist” systems. But how good are they, really, and will they overcome current limitations of large language models like OpenAI’s GPT or Google’s Gemini—such as the lack of robust reasoning capabilities, which are crucial for scientific discovery?

Epsiode 37: Medical machines get smarter - AI in Medtech

Epsiode 37: Medical machines get smarter - AI in Medtech

For Episode 37 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by joined by Julian Beimes, AI in MedTech expert at idalab, to explore how Artificial Intelligence (AI) is transforming the MedTech industry, from AI-powered imaging to smart diagnostics and remote monitoring.

Epsiode 28: Scientific Communication - Telling Stories that Matter

Epsiode 28:  Scientific Communication - Telling Stories that Matter

In episode 28 of the biorevolution podcast Andreas Horchler and Louise von Stechow talk about the science communication. Scientists often need to get our message out, during a pitch, a presentation at a scientific conference or in a grant application. To engage your audience, scientists can take a lead from the story telling principles used in fiction. In this episode we discuss story telling techniques drawing on sources such as Lisa Crohn’s story genius and Ted talks and translate those to scientific communication.

Epsiode 27: AI in drug development – Expanding the option space

Epsiode 27:  AI in drug development – Expanding the option space

In episode 27 of We’re doomed, We’re saved , the bio revolution podcast  Andreas Horchler and Louise von Stechow talk about the potential of Artificial Intelligence (AI) in drug discovery and development. The pharma industry is struggling with high development costs and failure rates. Can AI help to overcome those challenges, and what is hype and what is reality?

Epsiode 26: The future of medicine - trends, technologies and skills

Epsiode 26:  The future of medicine - trends, technologies and skills

In episode 26 of We’re doomed we’re saved we talk about the future trends in medicine, such as technologization, virtualization, predictive orientation and patient centration. These trends are corroborated by new technologies, such as artificial intelligence (AI), telemedicine, wearable devices and smart sensors.
Listen to We're doomed, We're saved, the bio revolution podcast with Andreas Horchler and Louise von Stechow here.